High confidence · Latest 100 of 119 total reviews analyzed · Based on 119 reviews. Signal may be noisy.

Frustrated

Recent user voice shows a frustrated sentiment. Users appreciate clinical utility, but report aggressive monetization and critical stability issues.

Rating: 4.5

Reviews: 119

Confidence: high

How did the latest release land?

Overall
3.0/ 5
(33.4K)
Current version
4.5/ 5
+1.4 vs overall
(7K)
Main signal post-update: clinical Utility.

Sentiment over time

Weekly average rating and review volume across stores, last 90 days.

Not enough recent reviews to plot a sentiment trend.

Review themes

Praise

What users love

  • Clinical Utility
    • Epocrates is daily used in my clinical practice for interaction checks and dosing.
Complaint

Common complaints

  • Aggressive Monetization
    • They have now put a limit on my 'free views' per week.
    • I am only able to look up 1 or 2 drugs A WEEK!
  • Critical Stability Issues
    • Since updating today, the app consistently crashes as soon as it loads.
    • New update made app unusable. Now won’t even open.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by epocrates: Drug Info & Pill ID, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0